Phase 2 clinical trial data published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated substantial weight loss in participants with obesity, though these findings were generated under tightly controlled conditions with rigorous medical supervision
On April 30, 2026, the FDA formally proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B outsourcing facility bulks list (Federal Register docket 2026-08552), citing no current clinical need for outsourcing facilities to compound these drugs from bulk drug substances
Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucosedependent insulinotropic polypeptide
This removes a major barrier and makes it easier to take the first step toward a patients health goals
As youre researching options, doctors advise against taking medications from unknown sellers or taking anything that hasnt been prescribed to you
If you want to compare this with broader GLP-1 storage guidance, review these GLP-1 expiration facts
